Transformative innovation: Advancing drug development using in silico modeling
Dear Kenneth,
In silico modeling has the potential to transform pharma’s approach to drug development and clinical research—but only when the data generated delivers actionable insights.
Learn more about the key capabilities of in silico modeling and how it supports smarter, faster decision-making across the development lifecycle.
Adding Value with Integrated Solutions
Pharma Ignite and Thermo Fisher Scientific take an inside look at how in silico modeling can shorten timelines, reduce costs, and increase the likelihood of technical success.
Read the white paper to gain insights into:
- Using predictive modeling to enhance solubility and bioavailability
- Applying accelerated stability modeling for shelf-life and packaging determination
- Optimizing tablet design and scale-up through in silico modeling of materials, compaction, and powder flow
- Predicting the impact of API physicochemical properties and pharmacokinetics using ADME-PK modeling
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.